The European Network for Sinonasal Cancer Research (EUSICA) – a pan-European initiative targeting a group of orphan tumours

Sinonasal cancers are a group of rare cancers which arise from the nasal cavities and paranasal sinuses and comprise of a wide spectrum of histologically distinct disease entities.[1] Diagnosis can be very challenging and treatment options are still very limited with some of these tumours having very dire clinical outcomes, e.g. sinonasal melanoma with a one- and five-year recurrence-free and overall survival of 61% and 22%, and 78% and 38%, respectively, similar to SNEC, SNUC, NUT and SMARCB1-deficient sinonasal carcinoma.

Source: European Journal of Cancer - February 21, 2024 Category: Cancer & Oncology Authors: Mario Hermsen, Paolo Bossi, David Capper, Jason Fleming, Johannes Haybaeck, Eva Martinez Balibrea, Sandra Nuyts, Alena Skalova, David Thomson, Annalisa Trama, Mario Turri-Zanoni, Benjamin Verillaud, Robbie Woods, Christian von Buchwald, Matt Lechner Tags: Editorial Source Type: research